PPP1R14A
PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A, also known as CPI-17 or PPP1INL) is a cytoplasmic member of the PP1 inhibitor family. It inhibits PPP1CA and acts as a phosphorylation-dependent switch in smooth muscle contraction. Browse Assay Genie's current range of PPP1R14A research reagents below, or read on for the biology behind the target.
PPP1R14A is an inhibitor of PPP1CA, the catalytic subunit of protein phosphatase 1 (PP1). Its inhibitory activity depends strongly on phosphorylation: the phosphorylated form is more than 1000-fold more potent than the unphosphorylated form. This creates a molecular switch that regulates the phosphorylation status of PPP1CA substrates and, in turn, smooth muscle contraction.
The NCBI Gene summary describes the protein as an inhibitor of smooth muscle myosin phosphatase. Inhibiting myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction. Because inhibition is gated by phosphorylation, PPP1R14A links upstream kinase signalling to the balance between kinase and phosphatase activity on myosin. This makes it a useful subject for studies of contractile regulation. The protein is found in the cytoplasm. The human PPP1R14A gene is also noted to produce alternatively spliced transcript variants that encode different isoforms, and orthologues are annotated in mouse and rat as Ppp1r14a.
PPP1R14A belongs to the PP1 inhibitor family and is classed by HGNC within the protein phosphatase 1 regulatory subunits. It is better known in the literature as CPI-17, and has the alias PPP1INL. The previous HGNC name was protein phosphatase 1, regulatory (inhibitor) subunit 14A. Researchers who study the PPP1R14A gene, PPP1R14A protein levels or its phosphorylation state often place the results alongside other PP1 catalytic and regulatory subunits.
PPP1R14A inhibits myosin phosphatase, raising myosin phosphorylation and enhancing smooth muscle contraction.
Its more than 1000-fold increase in inhibitory activity on phosphorylation makes it a model of switch-like control of PPP1CA.
As a member of the PP1 inhibitor family, it helps define how regulatory subunits tune PP1 substrate phosphorylation.
Its phosphorylation-dependent activity makes PPP1R14A relevant to work on kinase and phosphatase balance in the cytoplasm.
PPP1R14A inhibits PPP1CA, the catalytic subunit of protein phosphatase 1. Phosphorylation raises its inhibitory activity more than 1000-fold, so it works as a molecular switch. By inhibiting smooth muscle myosin phosphatase, it increases myosin phosphorylation and enhances smooth muscle contraction.
PPP1R14A is also called CPI-17 and PPP1INL. Its full name is protein phosphatase 1 regulatory inhibitor subunit 14A, and an earlier HGNC name was protein phosphatase 1, regulatory (inhibitor) subunit 14A. NCBI notes that alternatively spliced transcript variants encode different isoforms.
Orthologues of the human gene are annotated in mouse and rat, and both are named Ppp1r14a. This allows comparative work on PP1 inhibition in rodent models. Check the datasheet of any product for its validated reactivity.
Other PP1 catalytic and regulatory subunits, including related inhibitor proteins and myosin phosphatase components.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96A00; product specifications from Assay Genie datasheets.